Company / Shares Outstanding
Cartesian Therapeutics, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
25.8M
FY2025
5-year range
5.4M / 153.0M
FY2021-FY2025
Trend
+377.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding changed +377% YoY in FY2025, a notable deviation from the 7-year average annual change of +223%.
Based on SEC 10-K filings.
25767369.00 in FY2025 with a 5-year CAGR of -21.5%.
Improved from 153042435.00 to 25767369.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -40.7%
- 5-Year CAGR
- -21.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, shares outstanding increased 377.4% year-over-year.
- Peak shares outstanding was recorded in FY2023.
- Lowest shares outstanding in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 25.8M | +377.4% |
| FY2024 | 5.4M | -96.5% |
| FY2023 | 153.0M | +23.8% |
| FY2022 | 123.6M | +14.4% |
| FY2021 | 108.1M | +25.2% |
| FY2020 | 86.3M | +284.2% |
| FY2019 | 22.5M | +933.9% |
| FY2016 | 2.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026